Loracarbef

Usual Dosing (Adults)

UTI: 200 mg qd x 7 days.
Skin and soft tissue infections: 200 mg q12h x 7 days.
Uncomplicated pyelonephritis: 400 mg q12h x 14 days
Pharyngitis/tonsillitis: 200 mg q12h x 10 days
Sinusitis/Upper/lower respiratory tract infection: 400 mg q12h.

Renal Dosing

[CRCL >50 ml/min]: Administer usual dose.

[10-49]: Administer 50% of usual dose at usual interval or usual dose given half as often.
[<10 ]: Administer usual dose every 3-5 days.

Hemodialysis

Dose as for CrCl<10, on dialysis days give dose after dialysis

Reference(s)

National Institutes of Health, U.S. National Library of Medicine, DailyMed Database.
Provides access to the latest drug monographs submitted to the Food and Drug Administration (FDA). Please review the latest applicable package insert for additional information and possible updates. A local search option of this data can be found here.